How to Enter a Patient into the RITAZAREM Trial - Rare Disease

ePAPER READ

DOWNLOAD ePAPER

rarediseasesnetwork.epi.usf.edu

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

Chapter 2Upon completion of the form the following screen is displayed showing what treatment the subjecthas been assigned to. An email confirmation is sent.Ritazarem TENALEA End User Manual V1 Page 12 of 21

Clinical Trial Design Issues and Options for the Study of Rare Diseases

TENALEA User Manual Ritazarem Trial Version 1

Glossary and scoring for BVAS 2003. GENERAL ... - Rare Disease

THE DISEASE EXTENT INDEX (DEI) - Rare Diseases Clinical ...

Vasculitis: Current Concepts and Best Practices - Rare Disease

Chapter 2Picture 2.1.6. Confirmation of a successful randomisation, including the allocated patient kit2.2 Randomisation (INV/RN/PHARM/RM)Four months after enrollment (to within +/- 14 days) randomisation can take place. The relevantform on is found by navigating through the Ritazarem -> Investigator -> Subject Id -> Randomisation.The extra information to be collected at randomisation is:Prednisone Dose: must be

Page 1: Chapter 2Chapter 2: Selecting forms

How to Enter a Patient into the RITAZAREM Trial - Rare Disease

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?